FDA unlikely to rule on Merck’s COVID pill before December
How the brain ignores distracting information to coordinate movements
14 October 2021Molecular atlas of small cell lung cancer reveals unusual cell type that could explain why it’s so aggressive
14 October 2021FDA unlikely to rule on Merck’s COVID pill before December
The Food and Drug Administration said Thursday it will ask its outside experts to meet in late November to scrutinize Merck’s pill to treat COVID-19.
